Skip to content

Effect of Vitamin D2 and Vitamin D3 on serum 25-hydroxyvitamin D and parathyroid concentrations in healthy adult participants

Effect of vitamin D2 and vitamin D3 supplementation on serum 25-hydroxyvitamin D and parathyroid concentrations in healthy adult participants

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000273280
Enrollment
90
Registered
2009-05-15
Start date
2009-03-09
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Vitamin D is available in two forms, vitamin D2 and vitamin D3. Vitamin D3 is synthesized in the human body, whereas vitamin D2 is commonly used in supplements. It is not clear if the two forms have equivalent effects on serum 25-hydroxyvitamin D concentrations – the best measure of vitamin D status. To date, results of studies have yielded conflicting results because of problems with study design including small number of participants, short study duration and confounding effects of seasonal changes in serum 25-hydroxyvitamin D concentrations. We propose to evaluate the effects of daily doses of both vitamin D2 and vitamin D3 on serum changes in serum 25-hydroxyvitamin D and parathyroid concentrations over a sufficient period of time (4 mo). As most clinical and public health recommendations do not distinguish between vitamin D2 and D3, the results of this study will provide a definitive answer to whether these 2 distinct forms should be regarded as equivalent and interchangeable.

Interventions

vitamin D2 (ergocalciferol), vitamin D3 (cholecalciferol), both provided in a daily oral dose of 1000 IU, for a period of 6 months

Sponsors

University of Otago, Department of Human Nutrition
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy males and females

Exclusion criteria

Body mass index greater than 27kg/m2 Chronic liver and kidney disease Individuals taking medication, including anticonvulsants, glucocorticoids and barbiturates that might affect vitamin D metabolism Individuals who are currently taking a vitamin D supplement

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026